Biocon
Biocon Biologics Limited is a healthcare company based in Bengaluru, India, specializing in the development and commercialization of biopharmaceutical solutions. Incorporated in 2016, it operates as a subsidiary of Biocon Limited and focuses on producing high-quality, affordable biosimilars, novel biologics, and complex small molecule active pharmaceutical ingredients (APIs). The company is committed to expanding patient access to innovative therapies through its significant manufacturing capacity and cost-effective drug development capabilities. Biocon Biologics aims to address the humanitarian responsibility of the pharmaceutical industry by ensuring that essential medications are accessible to those in need, while also offering generic formulations in key markets such as the U.S. and Europe.
Fusion is head quartered in New Delhi and is operational in the less penetrated North Central part of India (Madhya Pradesh, Uttarakhand, Uttar Pradesh, Delhi and Haryana). The company started its Greenfield operations in January 2010 and further augmented it by acquiring the microfinance division Aajeevika (a not for profit body operating in Delhi). At the time of acquisition Aajeevika had a base of 1280 members with a loan book of Rs 6.3 million.
Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platform technology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.